Healthcare leaders are charting new courses to address complex financial challenges while driving innovation and transformation. Huron’s recent survey surfaces insights from 300 healthcare executives ...

October 14th, 2024 – machineMD, a Swiss medical device company innovating at the intersection of neuroscience and ...

About 40% of MA plans with prescription drug coverage will earn four or more stars, a dip from 42% this year, according to data released by the CMS.

While employers footed the bill for health plan price increases in 2024, they were largely unwilling to give employees access to popular weight loss drugs.

While Florida hospitals largely withstood the worst of the hurricane’s impacts, disruptions to public services could result in more patient transfers in the coming days.

Organizations must adopt a comprehensive approach to address the growing cybersecurity challenges in healthcare. A comprehensive cybersecurity strategy must be multi-layered to address every potential ...

Catalyst Solutions, a leader in innovative solutions to Health Plans, has announced today that Rob Renzi has joined the company as Chief Growth Officer. Renzi brings more than 35 years of leadership ...

Hospitals are contending with shortages of the life-saving supplies after Hurricane Helene damaged operations at a key manufacturing plant in North Carolina, according to the American Hospital ...

The products include a service that helps healthcare organizations build their own AI agents that could be used for appointment scheduling, clinical trial matching and patient triage.

Only 25% of Humana members will be in plans with four stars or above next year, down from 94% this year, the insurer disclosed Wednesday. The downgrade could wipe out Humana’s profits in 2026.

For any data-driven initiative, quality is crucial. In medical imaging, this means ensuring data is accurate, complete, and consistently labeled. Poor-quality imaging data can lead to inefficient ...

Jason Stenta, who has held roles at Optum and CVS Health, joins as the company considers selling its stake in VillageMD and contends with shareholder litigation.